Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway. | BMC Cancer | 2020 | 32641093 | PubTator, text mining | PubMed |
| Twenty years of t-loops: A case study for the importance of collaboration in molecular biology. | DNA Repair (Amst) | 2020 | 32620538 | PubTator, text mining | PubMed |
| Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants. | Genes (Basel) | 2020 | 32616706 | PubTator, text mining | PubMed |
| Yohimbine as a Starting Point to Access Diverse Natural Product-Like Agents with Re-programmed Activities against Cancer-Relevant GPCR Targets. | Bioorg Med Chem | 2020 | 32616180 | PubTator, text mining | PubMed |
| Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients. | Nat Commun | 2020 | 32601304 | PubTator, text mining | PubMed |
Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based on Transcriptomics and Chemical Informatics Methodology. | Front Pharmacol | 2020 | 32595497 | PubTator, text mining | PubMed |
| DCK is an Unfavorable Prognostic Biomarker and Correlated With Immune Infiltrates in Liver Cancer. | Technol Cancer Res Treat | 2020 | 32588770 | PubTator, text mining | PubMed |
| CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model. | Stem Cell Res Ther | 2020 | 32586381 | PubTator, text mining | PubMed |
| Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy. | Front Cell Dev Biol | 2020 | 32582698 | PubTator, text mining | PubMed |
| Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma. | Cell | 2020 | 32579974 | PubTator, text mining | PubMed |
| Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer. | Med Sci Monit | 2020 | 32562536 | PubTator, text mining | PubMed |
| Reconstruction of cell spatial organization from single-cell RNA sequencing data based on ligand-receptor mediated self-assembly. | Cell Res | 2020 | 32541867 | PubTator, text mining | PubMed |
| TGFβ2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer. | J Cell Mol Med | 2020 | 32530106 | PubTator, text mining | PubMed |
| SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer. | Front Oncol | 2020 | 32528869 | PubTator, text mining | PubMed |
| Cutaneous barrier dysfunction in allergic diseases. | J Allergy Clin Immunol | 2020 | 32507227 | PubTator, text mining | PubMed |
| The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. | Front Immunol | 2020 | 32499786 | PubTator, text mining | PubMed |
| Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment. | Mol Cell | 2020 | 32470318 | PubTator, text mining | PubMed |
| Effects of Cardiac Sympathetic Neurodegeneration and PPARγ Activation on Rhesus Macaque Whole Blood miRNA and mRNA Expression Profiles. | Biomed Res Int | 2020 | 32462037 | PubTator, text mining | PubMed |
| Personalized analysis of breast cancer using sample-specific networks. | PeerJ | 2020 | 32461838 | PubTator, text mining | PubMed |
| Intimate functional interactions between TGS1 and the Smn complex revealed by an analysis of the Drosophila eye development. | PLoS Genet | 2020 | 32453722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=63